Dr. Martens plc (LON:DOCS – Get Free Report) insider Giles Wilson bought 269 shares of the firm’s stock in a transaction on Tuesday, March 11th. The shares were purchased at an average cost of GBX 56 ($0.72) per share, with a total value of £150.64 ($194.85).
Giles Wilson also recently made the following trade(s):
- On Tuesday, February 11th, Giles Wilson bought 207 shares of Dr. Martens stock. The shares were purchased at an average cost of GBX 73 ($0.94) per share, with a total value of £151.11 ($195.46).
- On Monday, January 13th, Giles Wilson bought 222 shares of Dr. Martens stock. The shares were purchased at an average cost of GBX 68 ($0.88) per share, with a total value of £150.96 ($195.27).
Dr. Martens Stock Performance
LON:DOCS opened at GBX 53.80 ($0.70) on Friday. The company has a market capitalization of £522.27 million, a PE ratio of 7.63, a P/E/G ratio of 6.40 and a beta of 0.11. The company has a 50 day simple moving average of GBX 67.78 and a two-hundred day simple moving average of GBX 64.59. The company has a debt-to-equity ratio of 127.27, a quick ratio of 1.13 and a current ratio of 2.85. Dr. Martens plc has a fifty-two week low of GBX 49.32 ($0.64) and a fifty-two week high of GBX 99.40 ($1.29).
Dr. Martens Cuts Dividend
Dr. Martens Company Profile
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Further Reading
- Five stocks we like better than Dr. Martens
- CD Calculator: Certificate of Deposit Calculator
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- The 3 Best Fintech Stocks to Buy Now
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- How to Effectively Use the MarketBeat Ratings Screener
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for Dr. Martens Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr. Martens and related companies with MarketBeat.com's FREE daily email newsletter.